Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations
África Flores, Cyril Herry, Rafaël Maldonado, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 8, pp. 654-659
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
Clarissa D. Staton, Jazmine D. W. Yaeger, Delan Khalid, et al.
Neuropharmacology (2018) Vol. 143, pp. 79-94
Open Access | Times Cited: 59
Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
Cliff H. Summers, Jazmine D. W. Yaeger, Clarissa D. Staton, et al.
Brain Research (2018) Vol. 1731, pp. 146085-146085
Open Access | Times Cited: 59
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior
Jazmine D. W. Yaeger, Kevin T. Krupp, Benjamin Jacobs, et al.
Biological Psychiatry (2022) Vol. 91, Iss. 9, pp. 841-852
Open Access | Times Cited: 22
The Effect of Suvorexant on Fear Extinction Recall: A Double‐Blind Randomised Controlled Pilot Trial in Healthy Individuals
Maya T. Schenker, Lilith Z. Zeng, J Lynskey, et al.
Journal of Sleep Research (2025)
Open Access
Orexin Depolarizes Central Amygdala Neurons via Orexin Receptor 1, Phospholipase C and Sodium-Calcium Exchanger and Modulates Conditioned Fear
Erik T. Dustrude, Izabela Facco Caliman, Cristian Bernabe, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 39
Investigating the role of the amygdala orexin receptor 1 in memory acquisition and extinction in a rat model of PTSD
Sudabeh Salehabadi, Kataneh Abrari, Mahmoud Elahdadi Salmani, et al.
Behavioural Brain Research (2020) Vol. 384, pp. 112455-112455
Closed Access | Times Cited: 30
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112925-112925
Open Access | Times Cited: 18
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial
Sean Minns, Andrew Levihn‐Coon, Emily Carl, et al.
Journal of Anxiety Disorders (2018) Vol. 61, pp. 37-44
Closed Access | Times Cited: 31
Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits
Manoranjan S. D’Souza
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 29
Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial
Sean Minns, Andrew Levihn‐Coon, Emily Carl, et al.
Journal of Anxiety Disorders (2018) Vol. 58, pp. 1-7
Closed Access | Times Cited: 29
Predicting extinction phenotype to optimize fear reduction
Marie‐H. Monfils, Hongjoo J. Lee, Nicole E. Keller, et al.
Psychopharmacology (2018) Vol. 236, Iss. 1, pp. 99-110
Open Access | Times Cited: 24
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
David E. Moorman
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1663-1680
Open Access | Times Cited: 22
Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice
Sha Li, Paul Franken, Anne Vassalli
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear
Nadine Faesel, Malgorzata H. Kolodziejczyk, Michael Koch, et al.
Brain Research (2020) Vol. 1751, pp. 147199-147199
Closed Access | Times Cited: 16
The effects of orexin‐A and orexin receptors on anxiety‐ and depression‐related behaviors in a male rat model of post‐traumatic stress disorder
Dan Han, Yuxiu Shi, Fang Han
The Journal of Comparative Neurology (2021) Vol. 530, Iss. 3, pp. 592-606
Closed Access | Times Cited: 15
The role of basolateral amygdala orexin 1 receptors on the modulation of pain and psychosocial deficits in nitroglycerin-induced migraine model in adult male rats
Khadijeh Askari-Zahabi, Mehdi Abbasnejad, Razieh Kooshki, et al.
The Korean journal of pain (2021) Vol. 35, Iss. 1, pp. 22-32
Open Access | Times Cited: 14
Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity
Jazmine D. W. Yaeger, Kevin T. Krupp, Jason J. Gale, et al.
Medicine in Drug Discovery (2020) Vol. 8, pp. 100059-100059
Open Access | Times Cited: 14
Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
The role of the orexin system in the neurobiology of anxiety disorders: Potential for a novel treatment target
Harry Fagan, Nathan T. M. Huneke, Katharina Domschke, et al.
Neuroscience Applied (2023) Vol. 3, pp. 103922-103922
Open Access | Times Cited: 3
Orexin A Differentially Influences the Extinction Retention of Recent and Remote Fear Memory
Le Shi, Wenhao Chen, Jiahui Deng, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 9
Orexin one receptors within the basolateral amygdala are involved in the modulation of cognitive deficits associated with a migraine-like state in rats
Khadijeh Askari-Zahabi, Mehdi Abbasnejad, Razieh Kooshki, et al.
Neurological Research (2021) Vol. 43, Iss. 12, pp. 1087-1097
Closed Access | Times Cited: 8
Orexin 1 and 2 Receptors in the Prelimbic Cortex Modulate Threat Valuation
Victor P. M. N. Soares, Telma Gonçalves Carneiro Spera de Andrade, Newton S. Canteras, et al.
Neuroscience (2021) Vol. 468, pp. 158-167
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top